{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:21:13Z","timestamp":1790839273970,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR240"],"award-info":[{"award-number":["SFB-TR240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Gottfried Wilhelm Leibniz Program"],"award-info":[{"award-number":["Gottfried Wilhelm Leibniz Program"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR209 - 314905040"],"award-info":[{"award-number":["SFB-TR209 - 314905040"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR209 - 314905040"],"award-info":[{"award-number":["SFB-TR209 - 314905040"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR240"],"award-info":[{"award-number":["SFB-TR240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["403462768"],"award-info":[{"award-number":["403462768"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2314 - 267467939"],"award-info":[{"award-number":["FOR2314 - 267467939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR209 - 314905040"],"award-info":[{"award-number":["SFB-TR209 - 314905040"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008316","name":"Baden-W\u00fcrttemberg Stiftung","doi-asserted-by":"publisher","award":["Improve CRC"],"award-info":[{"award-number":["Improve CRC"]}],"id":[{"id":"10.13039\/100008316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008316","name":"Baden-W\u00fcrttemberg Stiftung","doi-asserted-by":"publisher","award":["Improve CRC"],"award-info":[{"award-number":["Improve CRC"]}],"id":[{"id":"10.13039\/100008316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008316","name":"Baden-W\u00fcrttemberg Stiftung","doi-asserted-by":"publisher","award":["Improve CRC"],"award-info":[{"award-number":["Improve CRC"]}],"id":[{"id":"10.13039\/100008316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-020-00168-3","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:22:21Z","timestamp":1613578941000},"page":"201-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["LXR\u03b1 activation and Raf inhibition trigger lethal lipotoxicity in liver cancer"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1742-0912","authenticated-orcid":false,"given":"Ramona","family":"Rudalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jule","family":"Harbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marteinn T.","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zwirner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmyla","family":"Taranets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Heinzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thales","family":"Kronenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"D\u2019Artista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-1281","authenticated-orcid":false,"given":"Elias","family":"Einig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hinterleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-7303","authenticated-orcid":false,"given":"Werner","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-1589","authenticated-orcid":false,"given":"Agata","family":"Dylawerska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-4204","authenticated-orcid":false,"given":"Antti","family":"Poso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias T.","family":"Rosenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar P.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd J.","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-6422","authenticated-orcid":false,"given":"Almut","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-2849","authenticated-orcid":false,"given":"Lars","family":"Zender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-5784","authenticated-orcid":false,"given":"Daniel","family":"Dauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"168_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature11706","volume":"491","author":"A Schulze","year":"2012","unstructured":"Schulze, A. & Harris, A. L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364\u2013373 (2012).","journal-title":"Nature"},{"key":"168_CR2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo, A., Gui, D. Y. & Vander Heiden, M. G. Targeting metabolism for cancer therapy. Cell Chem. Biol. 24, 1161\u20131180 (2017).","journal-title":"Cell Chem. Biol."},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens, K. et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature 566, 403\u2013406 (2019).","journal-title":"Nature"},{"key":"168_CR4","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2, 16018 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clinre.2011.12.011","volume":"36","author":"O Rosmorduc","year":"2012","unstructured":"Rosmorduc, O. & Fartoux, L. HCC and NASH: how strong is the clinical demonstration? Clin. Res. Hepatol. Gastroenterol. 36, 202\u2013208 (2012).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwalder, M. From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 16, 411\u2013428 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"168_CR7","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.3748\/wjg.14.6437","volume":"14","author":"T Yau","year":"2008","unstructured":"Yau, T., Chan, P., Epstein, R. & Poon, R. T. Evolution of systemic therapy of advanced hepatocellular carcinoma. World J. Gastroenterol. 14, 6437\u20136441 (2008).","journal-title":"World J. Gastroenterol."},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet, J. M., Montal, R., Sia, D. & Finn, R. S. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 15, 599\u2013616 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ctrv.2018.05.006","volume":"68","author":"JL Raoul","year":"2018","unstructured":"Raoul, J. L. et al. Systemic therapy for intermediate and advanced hepatocellular carcinoma: sorafenib and beyond. Cancer Treat. Rev. 68, 16\u201324 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"168_CR10","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn, R. S. et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N. Engl. J. Med. 382, 1894\u20131905 (2020).","journal-title":"N. Engl. J. Med."},{"key":"168_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.19.01307","volume":"38","author":"RS Finn","year":"2020","unstructured":"Finn, R. S. et al. Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial. J. Clin. Oncol. 38, 193\u2013202 (2020).","journal-title":"J. Clin. Oncol."},{"key":"168_CR12","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm.3679","volume":"20","author":"R Rudalska","year":"2014","unstructured":"Rudalska, R. et al. In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer. Nat. Med. 20, 1138\u20131146 (2014).","journal-title":"Nat. Med."},{"key":"168_CR13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nm.4107","volume":"22","author":"D Dauch","year":"2016","unstructured":"Dauch, D. et al. A MYC\u2212Aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer. Nat. Med. 22, 744\u2013753 (2016).","journal-title":"Nat. Med."},{"key":"168_CR14","doi-asserted-by":"crossref","unstructured":"Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547\u2013551 (2011).","DOI":"10.1038\/nature10599"},{"key":"168_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","volume":"562","author":"M Seehawer","year":"2018","unstructured":"Seehawer, M. et al. Necroptosis microenvironment directs lineage commitment in liver cancer. Nature 562, 69\u201375 (2018).","journal-title":"Nature"},{"key":"168_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0959-437X(98)80013-0","volume":"8","author":"DJ Peet","year":"1998","unstructured":"Peet, D. J., Janowski, B. A. & Mangelsdorf, D. J. The LXRs: a new class of oxysterol receptors. Curr. Opin. Genet. Dev. 8, 571\u2013575 (1998).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"168_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","volume":"13","author":"C Hong","year":"2014","unstructured":"Hong, C. & Tontonoz, P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat. Rev. Drug Discov. 13, 433\u2013444 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"168_CR18","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","volume":"14","author":"JR Schultz","year":"2000","unstructured":"Schultz, J. R. et al. Role of LXRs in control of lipogenesis. Genes Dev. 14, 2831\u20132838 (2000).","journal-title":"Genes Dev."},{"key":"168_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","volume":"93","author":"DJ Peet","year":"1998","unstructured":"Peet, D. J. et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR\u03b1. Cell 93, 693\u2013704 (1998).","journal-title":"Cell"},{"key":"168_CR20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cell.2014.01.038","volume":"156","author":"N Pencheva","year":"2014","unstructured":"Pencheva, N., Buss, C. G., Posada, J., Merghoub, T. & Tavazoie, S. F. Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation. Cell 156, 986\u20131001 (2014).","journal-title":"Cell"},{"key":"168_CR21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1073\/pnas.96.1.266","volume":"96","author":"BA Janowski","year":"1999","unstructured":"Janowski, B. A. et al. Structural requirements of ligands for the oxysterol liver X receptors LXR\u03b1 and LXR\u03b2. Proc. Natl Acad. Sci. USA 96, 266\u2013271 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"168_CR22","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","volume":"66","author":"L Liu","year":"2006","unstructured":"Liu, L. et al. Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5. Cancer Res. 66, 11851\u201311858 (2006).","journal-title":"Cancer Res."},{"key":"168_CR23","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","volume":"64","author":"SM Wilhelm","year":"2004","unstructured":"Wilhelm, S. M. et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 64, 7099\u20137109 (2004).","journal-title":"Cancer Res."},{"key":"168_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","volume":"4","author":"K Griffett","year":"2015","unstructured":"Griffett, K. et al. The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis. Mol. Metab. 4, 353\u2013357 (2015).","journal-title":"Mol. Metab."},{"key":"168_CR25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","volume":"514","author":"W Xue","year":"2014","unstructured":"Xue, W. et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 514, 380\u2013384 (2014).","journal-title":"Nature"},{"key":"168_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(02)03578-0","volume":"536","author":"N Terasaka","year":"2003","unstructured":"Terasaka, N. et al. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 536, 6\u201311 (2003).","journal-title":"FEBS Lett."},{"key":"168_CR27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/1535-7163.MCT-15-0617","volume":"15","author":"IC Waizenegger","year":"2016","unstructured":"Waizenegger, I. C. et al. A novel RAF kinase inhibitor with DFG-out-binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation. Mol. Cancer Ther. 15, 354 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"168_CR28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","volume":"6","author":"S Faivre","year":"2007","unstructured":"Faivre, S., Demetri, G., Sargent, W. & Raymond, E. Molecular basis for sunitinib efficacy and future clinical development. Nat. Rev. Drug Discov. 6, 734\u2013745 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"168_CR29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","volume":"30","author":"GR Villa","year":"2016","unstructured":"Villa, G. R. et al. An LXR\u2013cholesterol axis creates a metabolic co-dependency for brain cancers. Cancer Cell 30, 683\u2013693 (2016).","journal-title":"Cancer Cell"},{"key":"168_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/jpet.110.175786","volume":"337","author":"KF Chen","year":"2011","unstructured":"Chen, K. F. et al. Activation of phosphatidylinositol 3-kinase\/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J. Pharmacol. Exp. Ther. 337, 155\u2013161 (2011).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"168_CR31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224\u2013236 (2008).","journal-title":"Cell Metab."},{"key":"168_CR32","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/ars.2010.3834","volume":"15","author":"HY Kay","year":"2011","unstructured":"Kay, H. Y. et al. Nrf2 inhibits LXR\u03b1-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid. Redox Signal. 15, 2135\u20132146 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"168_CR33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan, C., Van, S. S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714\u2013726 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"168_CR34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2015.03.002","volume":"21","author":"F Bovenga","year":"2015","unstructured":"Bovenga, F., Sabba, C. & Moschetta, A. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer. Cell Metab. 21, 517\u2013526 (2015).","journal-title":"Cell Metab."},{"key":"168_CR35","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","volume":"113","author":"G Harriman","year":"2016","unstructured":"Harriman, G. et al. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc. Natl Acad. Sci. USA 113, E1796\u2013E1805 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"168_CR36","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/onc.2010.30","volume":"29","author":"AJ Pommier","year":"2010","unstructured":"Pommier, A. J. et al. Liver X receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 29, 2712\u20132723 (2010).","journal-title":"Oncogene"},{"key":"168_CR37","doi-asserted-by":"publisher","unstructured":"Nguyen, T. T. T. et al. Activation of LXR receptors and inhibition of TRAP1 causes synthetic lethality in solid tumors. Cancers https:\/\/doi.org\/10.3390\/cancers11060788 (2019).","DOI":"10.3390\/cancers11060788"},{"key":"168_CR38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","volume":"147","author":"D Wang","year":"2006","unstructured":"Wang, D., Wei, Y. & Pagliassotti, M. J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147, 943\u2013951 (2006).","journal-title":"Endocrinology"},{"key":"168_CR39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","volume":"24","author":"M Ricchi","year":"2009","unstructured":"Ricchi, M. et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol. 24, 830\u2013840 (2009).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"168_CR40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","volume":"5","author":"V Zambo","year":"2013","unstructured":"Zambo, V. et al. Lipotoxicity in the liver. World J. Hepatol. 5, 550\u2013557 (2013).","journal-title":"World J. Hepatol."},{"key":"168_CR41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89\u2013102 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"168_CR42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/MCB.21.4.1249-1259.2001","volume":"21","author":"KD McCullough","year":"2001","unstructured":"McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y. & Holbrook, N. J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21, 1249\u20131259 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"168_CR43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","volume":"19","author":"C Holze","year":"2018","unstructured":"Holze, C. et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat. Immunol. 19, 130\u2013140 (2018).","journal-title":"Nat. Immunol."},{"key":"168_CR44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202\u2013208 (2013).","journal-title":"Nat. Med."},{"key":"168_CR45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00041433-200306000-00005","volume":"14","author":"JM Ntambi","year":"2003","unstructured":"Ntambi, J. M. & Miyazaki, M. Recent insights into stearoyl-CoA desaturase-1. Curr. Opin. Lipidol. 14, 255\u2013261 (2003).","journal-title":"Curr. Opin. Lipidol."},{"key":"168_CR46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/1753-0407.12081","volume":"6","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXR\u03b1\u2013SREBP1c-dependent mechanism. J. Diabetes 6, 212\u2013220 (2014).","journal-title":"J. Diabetes"},{"key":"168_CR47","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1073\/pnas.97.16.8883","volume":"97","author":"H Mziaut","year":"2000","unstructured":"Mziaut, H., Korza, G. & Ozols, J. The N terminus of microsomal \u03949 stearoyl-CoA desaturase contains the sequence determinant for its rapid degradation. Proc. Natl Acad. Sci. USA 97, 8883\u20138888 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"168_CR48","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1242\/jcs.02951","volume":"119","author":"H Kato","year":"2006","unstructured":"Kato, H., Sakaki, K. & Mihara, K. Ubiquitin\u2013proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase. J. Cell Sci. 119, 2342\u20132353 (2006).","journal-title":"J. Cell Sci."},{"key":"168_CR49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ccell.2015.08.002","volume":"28","author":"SB Peng","year":"2015","unstructured":"Peng, S. B. et al. Inhibition of RAF isoforms and active dimers by LY3009120 leads to anti-tumor activities in RAS or BRAF mutant cancers. Cancer Cell 28, 384\u2013398 (2015).","journal-title":"Cancer Cell"},{"key":"168_CR50","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/0008-5472.CAN-17-2033","volume":"78","author":"W Shao","year":"2018","unstructured":"Shao, W. et al. Antitumor properties of RAF709, a highly selective and potent inhibitor of RAF kinase dimers, in tumors driven by mutant RAS or BRAF. Cancer Res. 78, 1537\u20131548 (2018).","journal-title":"Cancer Res."},{"key":"168_CR51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/17425255.2013.794220","volume":"9","author":"GT Gibney","year":"2013","unstructured":"Gibney, G. T. & Zager, J. S. Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies. Expert Opin. Drug Metab. Toxicol. 9, 893\u2013899 (2013).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"168_CR52","doi-asserted-by":"crossref","first-page":"11100","DOI":"10.1158\/0008-5472.CAN-06-2554","volume":"66","author":"AJ King","year":"2006","unstructured":"King, A. J. et al. Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res. 66, 11100\u201311105 (2006).","journal-title":"Cancer Res."},{"key":"168_CR53","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-06-1150","volume":"13","author":"TC Yeh","year":"2007","unstructured":"Yeh, T. C. et al. Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1\/2 inhibitor. Clin. Cancer Res. 13, 1576\u20131583 (2007).","journal-title":"Clin. Cancer Res."},{"key":"168_CR54","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1021\/acs.jmedchem.7b01306","volume":"61","author":"B Agianian","year":"2018","unstructured":"Agianian, B. & Gavathiotis, E. Current insights of BRAF inhibitors in cancer. J. Med. Chem. 61, 5775\u20135793 (2018).","journal-title":"J. Med. Chem."},{"key":"168_CR55","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1016\/j.bmcl.2008.06.088","volume":"18","author":"Z Xin","year":"2008","unstructured":"Xin, Z. et al. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Bioorg. Med. Chem. Lett. 18, 4298\u20134302 (2008).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"168_CR56","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","volume":"4","author":"JS Sebolt-Leopold","year":"2004","unstructured":"Sebolt-Leopold, J. S. & Herrera, R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4, 937\u2013947 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"168_CR57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549\u2013564 (2014).","journal-title":"Cancer Cell"},{"key":"168_CR58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13046-018-0872-6","volume":"37","author":"ZC Nwosu","year":"2018","unstructured":"Nwosu, Z. C. et al. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. J. Exp. Clin. Cancer Res. 37, 211 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"168_CR59","doi-asserted-by":"publisher","unstructured":"Preziosi, M. E. et al. In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/668350 (2019).","DOI":"10.1101\/668350"},{"key":"168_CR60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/jpet.114.219923","volume":"352","author":"TG Kirchgessner","year":"2015","unstructured":"Kirchgessner, T. G. et al. Pharmacological characterization of a novel liver X receptor agonist with partial LXR\u03b1 activity and a favorable window in nonhuman primates. J. Pharmacol. Exp. Ther. 352, 305\u2013314 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"168_CR61","doi-asserted-by":"crossref","first-page":"17059","DOI":"10.1073\/pnas.0502974102","volume":"102","author":"CM Carlson","year":"2005","unstructured":"Carlson, C. M., Frandsen, J. L., Kirchhof, N., McIvor, R. S. & Largaespada, D. A. Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. Proc. Natl Acad. Sci. USA 102, 17059\u201317064 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"168_CR62","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","volume":"125","author":"L Zender","year":"2006","unstructured":"Zender, L. et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253\u20131267 (2006).","journal-title":"Cell"},{"key":"168_CR63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1535-6108(03)00030-8","volume":"3","author":"RS Watnick","year":"2003","unstructured":"Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A. & Weinberg, R. A. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219\u2013231 (2003).","journal-title":"Cancer Cell"},{"key":"168_CR64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nbt.3807","volume":"35","author":"R Pelossof","year":"2017","unstructured":"Pelossof, R. et al. Prediction of potent shRNAs with a sequential classification algorithm. Nat. Biotechnol. 35, 350\u2013353 (2017).","journal-title":"Nat. Biotechnol."},{"key":"168_CR65","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","volume":"5","author":"C Fellmann","year":"2013","unstructured":"Fellmann, C. et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704\u20131713 (2013).","journal-title":"Cell Rep."},{"key":"168_CR66","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/bioinformatics\/btu743","volume":"31","author":"Y Naito","year":"2015","unstructured":"Naito, Y., Hino, K., Bono, H. & Ui-Tei, K. CRISPRdirect: software for designing CRISPR\/Cas guide RNA with reduced off-target sites. Bioinformatics 31, 1120\u20131123 (2015).","journal-title":"Bioinformatics"},{"key":"168_CR67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR\u2013Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"168_CR68","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"168_CR69","doi-asserted-by":"crossref","first-page":"prot087379","DOI":"10.1101\/pdb.prot087379","volume":"2016","author":"M Feoktistova","year":"2016","unstructured":"Feoktistova, M., Geserick, P. & Leverkus, M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb. Protoc. 2016, prot087379 (2016).","journal-title":"Cold Spring Harb. Protoc."},{"key":"168_CR70","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","volume":"8","author":"A Mehlem","year":"2013","unstructured":"Mehlem, A., Hagberg, C. E., Muhl, L., Eriksson, U. & Falkevall, A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat. Protoc. 8, 1149\u20131154 (2013).","journal-title":"Nat. Protoc."},{"key":"168_CR71","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"168_CR72","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki, S. et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 44, W147\u2013W153 (2016).","journal-title":"Nucleic Acids Res."},{"key":"168_CR73","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1128\/MCB.20.22.8602-8612.2000","volume":"20","author":"J Mendez","year":"2000","unstructured":"Mendez, J. & Stillman, B. Chromatin association of human origin recognition complex, Cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20, 8602\u20138612 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"168_CR74","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00168-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T09:59:00Z","timestamp":1710928740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1038\/s43018-020-00168-3","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}